LA JOLLA, Calif.: Co-authors: Adolfo García-Sastre, PhD, Icahn School of Medicine at Mount Sinai in New York – Director, Global Health and Emerging Pathogens Institute. Director, Center for Research on Influenza Pathogenesis (CRIP), National Institute of Allergy and Infectious Diseases (NIAID) Center of Excellence for Influenza Research and Surveillance.Kris White, PhD, Icahn School of Medicine at Mount Sinai in New York – Co-Investigator, National Institute of Health (NIH) Antiviral Drug Discovery (AViDD), AI-driven Structure-enabled Antiviral Platform (ASAP) Center and Quantitative Biosciences Institute Coronavirus Research Group (QCRG).David “Davey” Smith, MD, MAS, FACP, FIDSA, University of California, San Diego, School of Medicine – Assistant Vice Chancellor of Clinical and Translational Research. Director, Altman Clinical and Translational Research Institute (ACTRI). Director, Pandemic Response to Emerging Pathogens, Antimicrobial Resistance and Equity (PREPARE) Institute. Protocol Co-Chair, ACTIV-2.